Compass Therapeutics (CMPX) Interest Expenses (2018 - 2021)

Compass Therapeutics' Interest Expenses history runs 4 years deep, the most recent figure standing at $39000.0 for Q4 2021.

• In Q4 2021, Interest Expenses changed N/A year-over-year to $39000.0; the TTM figure through Sep 2022 stood at $39000.0 (down 82.27% YoY), while the FY2021 annual figure was $370000.0, down 59.25% from the prior year.
• Interest Expenses came in at $39000.0 for Q4 2021 at Compass Therapeutics, down from $78000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $314000.0 in Q2 2019 to a low of $580.0 in Q2 2018.
• A 4-year average of $134889.2 and a median of $110000.0 in 2021 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses soared 54037.93% in 2019 and sank 63.21% in 2021, its largest moves.
• Compass Therapeutics' Interest Expenses stood at $875.0 in 2018, then surged by 65.03% to $1444.0 in 2019, then jumped by 14581.44% to $212000.0 in 2020, then tumbled by 81.6% to $39000.0 in 2021.
• According to Business Quant data, Interest Expenses over the past three periods registered $39000.0, $78000.0, and $142000.0 for Q4 2021, Q3 2021, and Q1 2021 respectively.

Peer Comparison